Insight Inv LLC Pfizer Inc Transaction History

Insight Inv LLC

$148 Million
Q2 2025

A detailed history of Insight Inv LLC transactions in Pfizer Inc stock. As of the latest transaction made, Insight Inv LLC holds 8,651 shares of PFE stock, worth $209,613. This represents 0.14% of its overall portfolio holdings.

Number of Shares

8,651

Previous 19,339 55.27%

Holding current value

$209,613

Previous $490,000 57.35%

% of portfolio

0.14%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$21.59 - $24.84 $230,753 - $265,489	-10,688 Reduced 55.27%	8,651 $209,000
Q1 2025 Apr 25, 2025	BUY	$25.01 - $27.13 $250,074 - $271,272	9,999 Added 107.06%	19,339 $490,000
Q4 2024 Jan 21, 2025	BUY	$24.8 - $30.19 $231,632 - $281,974	9,340 New	9,340 $247,000
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $26,130 - $33,940	-1,000 Reduced 10.29%	8,715 $250,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $23,104 - $27,007	-720 Reduced 6.9%	9,715 $322,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $214,191 - $247,814	-5,930 Reduced 36.24%	10,435 $382,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $729,699 - $949,962	-18,525 Reduced 53.1%	16,365 $667,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $4,175 - $5,450	-100 Reduced 0.29%	34,890 $1.79 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $15,316 - $18,697	-350 Reduced 0.99%	34,990 $1.53 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $62,117 - $73,651	-1,335 Reduced 3.64%	35,340 $1.85 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $105,316 - $130,500	-2,302 Reduced 5.91%	36,675 $1.9 Million
Q4 2021 May 09, 2022	BUY	$41.32 - $61.25 $1.61 Million - $2.39 Million	38,977 New	38,977 $2.3 Million

Others Institutions Holding PFE

# of Institutions

3,335

Shares Held

3.61B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Inv LLC with notifications on news.

Account